Lecture 25+26 Flashcards
PKU generally
common (but rare)
autosomal recessive disorder
determined by mass spec.
responds well to treatment of low Phe diet
low protein, no eggs/milk/meat
no aspartate
can live normal life if following diet
biochemical defect in PKU
no phenylalanine hydrolase enzyme
thus more phenylalanine and less tyrosine
build up of phenylpyruvic acid
need tyrosine in diet
signs of PKU
delay milestones
low IQ
mousy odor of urine (due to Phe metabolite build up)
Phe levels are high in blood
decreased pigmentation of skin and hair
tyrosine conversion to melanin is inhibited by high phe levels; inhibits tyrosinase
Treatment for those with PKU
dietary treatment- avoid phenylalanine
sapropterin (synthetic form of BH4)
typically for mild or moderate forms of disease
mutant from of enzyme that has low affinity for BH4
first non-diet treatment considered
maternal PKU syndrome
women with PKU must maintain low levels of Phe before conception and pregnancy
high maternal blood levels of Phe:
microcephaly
lack of mental development
congenital heart defects
elevated Phe has teratogenic properties!!
does not matter if fetus has PKU or not
alkaptonuria
homogentisic acid oxidase deficiency
build up of homogentisic acid
dietary restriction of Phe and tyrosine may reduce the deposits of homogentisic acid
alkaptonuria signs
darkening of the urine on standing
discoloration of the cartilage and connective tissues
(ochronotic pigment)
leads to arthritis
these symptoms are due to the oxidation of homogentisic acid
tyrosinemia type I
build up of fumaryl acetoacetate
leads to kidney and liver damage
cabbage-like smell of the urine
tyrosinosis or tyrosinemia type I
inborn error of phenylalanine tyrosine metabolism
seen to have a fumarylacetoacetate hydrolase deficiency
liver and kidney failure
cabbage smell to urine
dietary restriction of phe and tyr
difficult to accomplish
maple syrup urine disease (MSUD)
symptoms occur in neonates aged 4-7 days
can be detected by neonatal screening
signs/symptoms: poor feeding vomiting lethargy seizures ketosis (sweet smell of urine) coma / death if not treated
biochemical defect in MSUD
cannot break down branched chain amino acids
No Branched chain α-keto acid dehydrogenase
thus build of of branched amino acids
treatment for MSUD
No intake of leucine, isoleucine, or valine
improves neurological functions
difficult to treat
BCAA found in most protein sources and are essential
dietary supplementation of B1 in those that have a low affinity enzyme
regular checking of BCAA in blood
Methylmalonyl CoA mutase deficiency
results increased levels of methylmalonic acid in circulation
will lead to metabolic acidosis
can have seizures and encephalopathy
sometimes have improvement with B12 supplementation
homocystinuria
defect in the metabolism of homocysteine
high plasma and urinary levels of homocysteine
due to a deficiency in cystathionine Beta synthase (transulfuration pathway)
homocystinuria signs/symptoms
homocysteine can bind to connective tissues and disrupt structure
dislocation of lens (after age 3) skeletal abnormalities osteoporosis delay in mental development premature arterial disease (lipid deposits) (lipid oxidation and platelet aggregation)
may respond to vit B6 supplement